Cargando…

Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer

BACKGROUND: Obstructive colorectal cancer (OCC) is always accompanied by severe complications, and the optimal strategy for patients with OCC remains undetermined. Different from emergency surgery (ES), self-expandable metal stents (SEMS) as a bridge to surgery (BTS), could increase the likelihood o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xian-Qiang, Xue, Chao-Rong, Hou, Ping, Lin, Bing-Qiang, Zhang, Jun-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737316/
https://www.ncbi.nlm.nih.gov/pubmed/31543687
http://dx.doi.org/10.3748/wjg.v25.i33.4970
_version_ 1783450646025863168
author Chen, Xian-Qiang
Xue, Chao-Rong
Hou, Ping
Lin, Bing-Qiang
Zhang, Jun-Rong
author_facet Chen, Xian-Qiang
Xue, Chao-Rong
Hou, Ping
Lin, Bing-Qiang
Zhang, Jun-Rong
author_sort Chen, Xian-Qiang
collection PubMed
description BACKGROUND: Obstructive colorectal cancer (OCC) is always accompanied by severe complications, and the optimal strategy for patients with OCC remains undetermined. Different from emergency surgery (ES), self-expandable metal stents (SEMS) as a bridge to surgery (BTS), could increase the likelihood of primary anastomosis. However, the stent failure and related complications might give rise to a high recurrence rate. Few studies have focused on the indications for either method, and the relationship between preoperative inflammation indexes and the prognosis of OCC is still underestimated. AIM: To explore the indications for ES and BTS in OCCs based on preoperative inflammation indexes. METHODS: One hundred and twenty-eight patients who underwent ES or BTS from 2008 to 2015 were enrolled. Receiver operating characteristic (ROC) curve analysis was used to define the optimal preoperative inflammation index and its cutoff point. Kaplan–Meier analyses and Cox proportional hazards models were applied to assess the association between the preoperative inflammation indexes and the survival outcomes [overall survival (OS) and disease-free survival (DFS)]. Stratification analysis was performed to identify the subgroups that would benefit from ES or BTS. RESULTS: OS and DFS were comparable between the ES and BTS groups (P > 0.05). ROC curve analysis showed derived neutrophil-to-lymphocyte ratio (dNLR) as the optimal biomarker for the prediction of DFS in ES (P < 0.05). Lymphocyte-to-monocyte ratio (LMR) was recommended for BTS with regard to OS and DFS (P < 0.05). dNLR was related to stoma construction (P = 0.001), pneumonia (P = 0.054), and DFS (P = 0.009) in ES. LMR was closely related to lymph node invasion (LVI) (P = 0.009), OS (P = 0.020), and DFS (P = 0.046) in the BTS group. dNLR was an independent risk factor for ES in both OS (P = 0.032) and DFS (P = 0.016). LMR affected OS (P = 0.053) and DFS (P = 0.052) in the BTS group. LMR could differentiate the OS between the ES and BTS groups (P < 0.05). CONCLUSION: Preoperative dNLR and LMR could predict OS and DFS in patients undergoing ES and BTS, respectively. For OCC, as the potential benefit group, patients with a low LMR might be preferred for BTS via SEMS insertion.
format Online
Article
Text
id pubmed-6737316
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-67373162019-09-22 Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer Chen, Xian-Qiang Xue, Chao-Rong Hou, Ping Lin, Bing-Qiang Zhang, Jun-Rong World J Gastroenterol Retrospective Study BACKGROUND: Obstructive colorectal cancer (OCC) is always accompanied by severe complications, and the optimal strategy for patients with OCC remains undetermined. Different from emergency surgery (ES), self-expandable metal stents (SEMS) as a bridge to surgery (BTS), could increase the likelihood of primary anastomosis. However, the stent failure and related complications might give rise to a high recurrence rate. Few studies have focused on the indications for either method, and the relationship between preoperative inflammation indexes and the prognosis of OCC is still underestimated. AIM: To explore the indications for ES and BTS in OCCs based on preoperative inflammation indexes. METHODS: One hundred and twenty-eight patients who underwent ES or BTS from 2008 to 2015 were enrolled. Receiver operating characteristic (ROC) curve analysis was used to define the optimal preoperative inflammation index and its cutoff point. Kaplan–Meier analyses and Cox proportional hazards models were applied to assess the association between the preoperative inflammation indexes and the survival outcomes [overall survival (OS) and disease-free survival (DFS)]. Stratification analysis was performed to identify the subgroups that would benefit from ES or BTS. RESULTS: OS and DFS were comparable between the ES and BTS groups (P > 0.05). ROC curve analysis showed derived neutrophil-to-lymphocyte ratio (dNLR) as the optimal biomarker for the prediction of DFS in ES (P < 0.05). Lymphocyte-to-monocyte ratio (LMR) was recommended for BTS with regard to OS and DFS (P < 0.05). dNLR was related to stoma construction (P = 0.001), pneumonia (P = 0.054), and DFS (P = 0.009) in ES. LMR was closely related to lymph node invasion (LVI) (P = 0.009), OS (P = 0.020), and DFS (P = 0.046) in the BTS group. dNLR was an independent risk factor for ES in both OS (P = 0.032) and DFS (P = 0.016). LMR affected OS (P = 0.053) and DFS (P = 0.052) in the BTS group. LMR could differentiate the OS between the ES and BTS groups (P < 0.05). CONCLUSION: Preoperative dNLR and LMR could predict OS and DFS in patients undergoing ES and BTS, respectively. For OCC, as the potential benefit group, patients with a low LMR might be preferred for BTS via SEMS insertion. Baishideng Publishing Group Inc 2019-09-07 2019-09-07 /pmc/articles/PMC6737316/ /pubmed/31543687 http://dx.doi.org/10.3748/wjg.v25.i33.4970 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Chen, Xian-Qiang
Xue, Chao-Rong
Hou, Ping
Lin, Bing-Qiang
Zhang, Jun-Rong
Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
title Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
title_full Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
title_fullStr Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
title_full_unstemmed Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
title_short Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
title_sort lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737316/
https://www.ncbi.nlm.nih.gov/pubmed/31543687
http://dx.doi.org/10.3748/wjg.v25.i33.4970
work_keys_str_mv AT chenxianqiang lymphocytetomonocyteratioeffectivelypredictssurvivaloutcomeofpatientswithobstructivecolorectalcancer
AT xuechaorong lymphocytetomonocyteratioeffectivelypredictssurvivaloutcomeofpatientswithobstructivecolorectalcancer
AT houping lymphocytetomonocyteratioeffectivelypredictssurvivaloutcomeofpatientswithobstructivecolorectalcancer
AT linbingqiang lymphocytetomonocyteratioeffectivelypredictssurvivaloutcomeofpatientswithobstructivecolorectalcancer
AT zhangjunrong lymphocytetomonocyteratioeffectivelypredictssurvivaloutcomeofpatientswithobstructivecolorectalcancer